Stockscreener 앱 받기
12.07
3.07%
0.33
Novocure Ltd 주식(NVCR)의 최신 뉴스
NovoCure (NVCR): Assessing Valuation After a Steep Drawdown and Recent Share Price Uptick - simplywall.st
NovoCure (NASDAQ:NVCR) Stock Price Up 7%Time to Buy? - MarketBeat
What is the fair value estimate for NovoCure Limited (038) stock in 2025Weekly Trade Report & Verified Stock Trade Ideas - Newser
Is NovoCure’s 93% Five Year Share Price Slide Now Creating an Opportunity in 2025? - Yahoo Finance UK
NovoCure Limited $NVCR Shares Purchased by American Century Companies Inc. - MarketBeat
NovoCure stock rating reiterated at Buy by H.C. Wainwright amid CEO change - Investing.com Nigeria
Can NovoCure's Tumor Treating Fields Redefine Cancer Care By 2026? - RTTNews
Novocure names Frank Leonard as new CEO, replacing Ashley Cordova By Investing.com - Investing.com Australia
How Investors Are Reacting To NovoCure (NVCR) CEO Transition as Frank Leonard Takes the Helm - simplywall.st
Novocure CEO Ashley Cordova resigns, Frank Leonard succeeds - TipRanks
Novocure (NVCR) Appoints New CEO Amid Leadership Change - GuruFocus
Novocure (NASDAQ: NVCR) elevates President Frank Leonard to CEO as Ashley Cordova resigns - Stock Titan
NovoCure’s LUNAR-2 Study: A New Horizon in Lung Cancer Treatment - MSN
Novocure (NASDAQ: NVCR) to Present at 37th Piper Sandler Healthcare Conference on Dec. 2 - Stock Titan
NovoCure Limited (NVCR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will NovoCure Limited stock attract more institutional investorsInsider Buying & Breakout Confirmation Trade Signals - newser.com
Novocure at Jefferies London: Expanding Horizons in Cancer Treatment By Investing.com - Investing.com South Africa
Tangible book value per share of NovoCure Ltd. – DUS:038 - TradingView
Published on: 2025-11-19 05:31:32 - newser.com
Will NovoCure Limited stock benefit from green energy trendsPrice Action & AI Forecasted Entry/Exit Points - newser.com
NovoCure Limited (NVCR) Stock Forecast 2026, 2030 & 7-Year Price Prediction | Meyka AI - Meyka
Using flow based indicators on NovoCure LimitedTrade Performance Summary & Safe Entry Zone Identification - newser.com
Why NovoCure Limited (038) stock could rally strongly2025 Analyst Calls & Weekly Watchlist of Top Performers - newser.com
How interest rate cuts could boost NovoCure Limited stockWeekly Gains Summary & Verified Entry Point Signals - newser.com
What sentiment indicators say about NovoCure Limited stockMarket Risk Report & Verified Short-Term Plans - newser.com
Can NovoCure Limited stock deliver sustainable ROEEarnings Beat & Risk Managed Investment Entry Signals - newser.com
NovoCure (NVCR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Published on: 2025-11-14 04:19:47 - newser.com
Should Rising Losses Despite Higher Sales Require Action From NovoCure (NVCR) Investors? - simplywall.st
NVCR (NovoCure) ROA % : -11.44% (As of Sep. 2025) - GuruFocus
2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon - Yahoo Finance
Novocure (NASDAQ: NVCR) at Jefferies Healthcare, 2:00 p.m. GMT; webcast, 14-day replay - Stock Titan
NovoCure (NVCR): Assessing Valuation Following Q3 Sales Growth and Rising Net Losses - simplywall.st
Novocure stock hits 52-week low at 10.82 USD By Investing.com - Investing.com Australia
Novocure stock hits 52-week low at 10.82 USD - Investing.com
Can NovoCure Limited hit a new high this monthM&A Rumor & Fast Entry High Yield Stock Tips - newser.com
Can momentum traders help lift NovoCure LimitedMarket Trend Report & Reliable Intraday Trade Plans - newser.com
Oversold Conditions For NovoCure (NVCR) - Nasdaq
[Form 4] NovoCure Ltd Insider Trading Activity - Stock Titan
Novocure Ltd. Reports Q3 2025 Financial Results - MSN
1.36%
1.27%
자본화:
|
볼륨(24시간):